Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia

Xing,Hongxia; Guo,Shuangxi; Zhang,Yi; Zheng,Zhiyong; Wang,Haoliang

doi:10.3892/mmr.2016.5369

Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia

Authors:
- Hongxia Xing
- Shuangxi Guo
- Yi Zhang
- Zhiyong Zheng
- Haoliang Wang
View Affiliations

Affiliations: Department of Neurology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China
Published online on: June 6, 2016 https://doi.org/10.3892/mmr.2016.5369
Pages: 1357-1364

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Activated microglia are capable of facilitating amyloid-β (Aβ) accumulation via the release of inflammatory factors, thus resulting in the exacerbation of Alzheimer's disease (AD). MicroRNAs (miRs) participate in the activation of microglia, which is associated with AD. Insulin-like growth factor 1 (IGF1) is a neuroprotective, anti-inflammatory factor, which is able to accelerate clearance of Aβ peptides. The present study aimed to investigate the precise role of miR‑206 and IGF1 in lipopolysaccharide (LPS)‑induced microglial inflammation. The expression levels of miR‑206 and IGF1 were detected in 60 peripheral blood samples from patients with AD and matched age subjects using quantitative polymerase chain reaction. A dual luciferase reporter gene assay was used to indicate the relationship between miR‑206 and IGF1. In addition, the role of miR‑206 was determined by gain and loss of function experiments in LPS‑treated microglia. The results demonstrated that miR‑206 upregulation enhanced LPS‑induced inflammation and Aβ release in microglia by directly targeting the 3'-untranslated region of IGF1. These effects were attenuated following treatment with exogenous IGF1, thus indicating that the miR‑206/IGF1 signaling pathway may be considered a novel therapeutic target for the treatment of AD‑associated microglial inflammation.

View Figures

View References

1	Wu Z and Nakanishi H: Connection between periodontitis and Alzheimer's disease: Possible roles of microglia and leptomeningeal cells. J Pharmacol Sci. 126:8–13. 2014. View Article : Google Scholar : PubMed/NCBI
2	Latta CH, Sudduth TL, Weekman EM, Brothers HM, Abner EL, Popa GJ, Mendenhall MD, Gonzalez-Oregon F, Braun K and Wilcock DM: Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice. J Neuroinflammation. 12:412015. View Article : Google Scholar
3	Zhang F and Jiang L: Neuroinflammation in Alzheimer's disease. Neuropsychiatr Dis Treat. 11:243–256. 2015. View Article : Google Scholar : PubMed/NCBI
4	Doens D and Fernandez PL: Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis. J Neuroinflammation. 11:482014. View Article : Google Scholar
5	Guedes J, Cardoso AL and Pedroso de Lima MC: Involvement of microRNA in microglia-mediated immune response. Clin Dev Immunol. 2013:1868722013. View Article : Google Scholar : PubMed/NCBI
6	Su W, Hopkins S, Nesser NK, Sopher B, Silvestroni A, Ammanuel S, Jayadev S, Möller T, Weinstein J and Garden GA: The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf. J Immunol. 192:358–366. 2014. View Article : Google Scholar
7	Fenn AM, Smith KM, Lovett-Racke AE, Guerau-de-Arellano M, Whitacre CC and Godbout JP: Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand. Neurobiol Aging. 34:2748–2758. 2013. View Article : Google Scholar : PubMed/NCBI
8	Louafi F, Martinez-Nunez RT and Sanchez-Elsner T: MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem. 285:41328–41336. 2010. View Article : Google Scholar : PubMed/NCBI
9	Duan X, Zohaib A, Li Y, Zhu B, Ye J, Wan S, Xu Q, Song Y, Chen H and Cao S: MiR-206 modulates lipopolysaccharide-mediated inflammatory cytokine production in human astrocytes. Cell Signal. 27:61–68. 2015. View Article : Google Scholar
10	Fernandez AM and Torres-Alemán I: The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci. 13:225–239. 2012. View Article : Google Scholar : PubMed/NCBI
11	Carro E, Trejo JL, Gomez-Isla T, LeRoith D and Torres-Aleman I: Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med. 8:1390–1397. 2002. View Article : Google Scholar : PubMed/NCBI
12	Trueba-Sáiz A, Cavada C, Fernandez AM, Leon T, Gonzalez DA, Fortea OJ, Fortea Ormaechea J, Lleó A, Del Ser T, Nuñez A and Torres-Aleman I: Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice. Transl Psychiatry. 3:e3302013. View Article : Google Scholar : PubMed/NCBI
13	Wang W, Yu JT, Tan L, Liu QY, Wang HF and Ma XY: Insulin-like growth factor 1 (IGF1) polymorphism is associated with Alzheimer's disease in Han Chinese. Neurosci Lett. 531:20–23. 2012. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Hsieh CH, Rau CS, Jeng JC, Chen YC, Lu TH, Wu CJ, Wu YC, Tzeng SL and Yang JC: Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides. J Biomed Sci. 19:692012. View Article : Google Scholar : PubMed/NCBI
16	Theriault P, ElAli A and Rivest S: The dynamics of monocytes and microglia in Alzheimer's disease. Alzheimers Res Ther. 7:412015. View Article : Google Scholar : PubMed/NCBI
17	Suh HS, Zhao ML, Derico L, Choi N and Lee SC: Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: Differential regulation by inflammatory mediators. J Neuroinflammation. 10:372013. View Article : Google Scholar : PubMed/NCBI
18	McGeer PL and McGeer EG: Targeting microglia for the treatment of Alzheimer's disease. Expert Opin Ther Targets. 19:497–506. 2015. View Article : Google Scholar
19	Cai Z, Hussain MD and Yan LJ: Microglia, neuroinflammation and beta-amyloid protein in Alzheimer's disease. Int J Neurosci. 124:307–321. 2014. View Article : Google Scholar
20	Tan L, Yu JT, Hu N and Tan L: Non-coding RNAs in Alzheimer's disease. Mol Neurobiol. 47:382–393. 2013. View Article : Google Scholar
21	Schonrock N and Gotz J: Decoding the non-coding RNAs in Alzheimer's disease. Cell Mol Life Sci. 69:3543–3559. 2012. View Article : Google Scholar : PubMed/NCBI
22	Muller M, Kuiperij HB, Claassen JA, Kusters B and Verbeek MM: MicroRNAs in Alzheimer's disease: Differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging. 35:152–158. 2014. View Article : Google Scholar
23	Tian N, Cao Z and Zhang Y: MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer's disease. Neurosci Bull. 30:191–197. 2014. View Article : Google Scholar : PubMed/NCBI
24	Lee ST, Chu K, Jung KH, Kim JH, Huh JY, Yoon H, Park DK, Lim JY, Kim JM, Jeon D, et al: MiR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol. 72:269–277. 2012. View Article : Google Scholar : PubMed/NCBI
25	Xie B, Zhou H, Zhang R, Song M, Yu L, Wang L, Liu Z, Zhang Q, Cui D, Wang X and Xu S: Serum miR-206 and miR-132 as potential circulating biomarkers for mild cognitive impairment. J Alzheimers Dis. 45:721–731. 2015.PubMed/NCBI
26	Jarvis K, Assis-Nascimento P, Mudd LM and Montague JR: Beta-amyloid toxicity and reversal in embryonic rat septal neurons. Neurosci Lett. 423:184–188. 2007. View Article : Google Scholar : PubMed/NCBI
27	Luo YW, Xu Y, Cao WY, Zhong XL, Duan J, Wang XQ, Hu ZL, Li F, Zhang JY, Zhou M, et al: Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress. Neuropharmacology. 89:318–324. 2015. View Article : Google Scholar
28	Mellott TJ, Pender SM, Burke RM, Langley EA and Blusztajn JK: IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. PLoS One. 9:e942872014. View Article : Google Scholar : PubMed/NCBI
29	Pascual-Lucas M, Viana da Silva S, Di Scala M, Garcia-Barroso C, González-Aseguinolaza G, Mulle C, Cuadrado-Tejedor M and Garcia-Osta A: Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Mol Med. 6:1246–1262. 2014. View Article : Google Scholar : PubMed/NCBI
30	Johansson JU, Woodling NS, Wang Q, Panchal M, Liang X, Trueba-Saiz A, Brown HD, Mhatre SD, Loui T and Andreasson KI: Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. J Clin Invest. 125:350–364. 2015. View Article : Google Scholar